These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11692657)

  • 1. New innovations and developments for glioma treatment.
    Croteau D; Mikkelsen T; Rempel SA; Bogler O; Rosenblum M
    Clin Neurosurg; 2001; 48():60-81. PubMed ID: 11692657
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular characterization of brain tumors.
    Boudreau CR; Liau LM
    Clin Neurosurg; 2004; 51():81-90. PubMed ID: 15571131
    [No Abstract]   [Full Text] [Related]  

  • 3. [Latest treatment strategies for malignant gliomas].
    Shono T; Mizoguchi M; Sasaki T
    Fukuoka Igaku Zasshi; 2007 Sep; 98(9):333-6. PubMed ID: 17974076
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head's up on the treatment of malignant glioma patients.
    Armstrong TS
    Oncol Nurs Forum; 2009 Sep; 36(5):E232-40. PubMed ID: 19726382
    [No Abstract]   [Full Text] [Related]  

  • 6. [Malignant gliomas. Oncogenic considerations].
    Pérez-Ortiz L; Zaldívar-Vaillant T; Tamayo-Suárez JD
    Rev Neurol; 2000 Jul 1-15; 31(1):49-52. PubMed ID: 10948584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of malignant brain tumors by using apoptosis].
    Kuchino Y
    No To Shinkei; 1995 Sep; 47(9):829-34. PubMed ID: 7546931
    [No Abstract]   [Full Text] [Related]  

  • 8. BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells.
    Weiler M; Bähr O; Hohlweg U; Naumann U; Rieger J; Huang H; Tabatabai G; Krell HW; Ohgaki H; Weller M; Wick W
    Cell Death Differ; 2006 Jul; 13(7):1156-69. PubMed ID: 16254573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radio-responsive TRAIL gene therapy for malignant gliomas.
    Kyritsis AP; Rao JS; Puduvalli VK
    Cancer Gene Ther; 2007 Dec; 14(12):1002. PubMed ID: 17704752
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prognostic factors in malignant glioma in elderly patients].
    Nishihara M; Taomoto K; Kohmura E
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():596-9. PubMed ID: 16201587
    [No Abstract]   [Full Text] [Related]  

  • 11. [Progress in the study of neurosurgery China].
    Zhao Y; Lin S
    Zhonghua Yi Xue Za Zhi; 1998 Dec; 78(12):909-10. PubMed ID: 11038855
    [No Abstract]   [Full Text] [Related]  

  • 12. Translational research strategies applied to glioma therapeutics.
    Berger MS; Keles GE
    Clin Neurosurg; 2004; 51():203-6. PubMed ID: 15571146
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gene therapy for brain tumors: induction of apoptosis and immunogenic modulation in glioma cells (series 5)].
    Asai A
    No Shinkei Geka; 1995 Jan; 23(1):7-15. PubMed ID: 7845524
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost of migration: invasion of malignant gliomas and implications for treatment.
    Giese A; Bjerkvig R; Berens ME; Westphal M
    J Clin Oncol; 2003 Apr; 21(8):1624-36. PubMed ID: 12697889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling and preclinical trials for gliomas.
    Salpietro M; Holland EC
    Clin Neurosurg; 2005; 52():104-11. PubMed ID: 16626060
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
    Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY
    Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of diffuse glioma in children: a retrospective study of 27 cases and review of literature.
    Piette C; Deprez M; Born J; Michotte A; Munaut C; Closon MT; Rutten I; Dresse MF; Forget P; Schmitz V; Misson JP; Hoyoux C
    Acta Neurol Belg; 2008 Jun; 108(2):35-43. PubMed ID: 18795594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adult diffuse glioma: genetic heterogeneity and therapeutic implications].
    Verreault M; Delattre JY; Idbaih A
    Med Sci (Paris); 2012 Oct; 28(10):813-6. PubMed ID: 23067408
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential confounding features in p53 gene therapy of recurrent glioma.
    Weil RJ
    J Clin Oncol; 2004 Apr; 22(7):1344-5; author reply 1345. PubMed ID: 15051789
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene therapy for malignant glioma.
    Lesniak MS
    Expert Rev Neurother; 2006 Apr; 6(4):479-88. PubMed ID: 16623647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.